Forepont Capital Partners deploy long-term capital to fuel growth of new medicines and technologies that drive better healthcare outcomes. Our strategic partnerships bring a unique combination of experience, expertise and banking know how.
Forepont Capital Partners deploy long-term capital to fuel growth of new medicines and technologies that drive better healthcare outcomes. The team has an outstanding track record of high growth exits and return to investors.
Genomics, imaging, and biomarkers that translate into the development and use of systems therapeutics. Systems Therapeutics - medicines that target specific pathways to modify the course of disease and are intended for personalized or stratified use in specific patient populations to drive better outcomes along with reduced adverse effects. The right drug for the right disease in the right patient.
Data, wearables, mobile apps and other technologies that enable more rapid changes to treatment protocols, increasing patient engagement and accountability, shifting patient-provider interaction, and accelerating the adoption of behavior changes that will improve patient adherence to treatments, manage their condition and adapt lifestyle to enable better healthcare outcomes at lower costs.